Nanologica AB (publ) has changed the previously disclosed publication date of May 7, 2021 for the Company’s interim report for the first quarter 2021 to April 23, 2021.
In addition, the date for the interim report for the second quarter 2021 has been changed from August 27, 2021 to July 9, 2021.
Financial calendar 2021
Interim report January-March 2021 April 23, 2021
Annual Report 2020 April 23, 2021
Interim report January-June 2021 July 9, 2021
Interim report January-September 2021 October 29, 2021
For further information, please contact:
Johanna Johansson, IR Nanologica
Ph: +46 72 211 21 90 or e-mail: firstname.lastname@example.org
About Nanologica AB (publ)
Nanologica manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface characteristics of silica particles. Through the two business areas, Drug Development and Chromatography, we are serving the industry by providing products for developing better and cheaper medicine for the benefits of patients. Nanologica operates from the headquarters in Södertälje, Sweden and Nanologica’s stock (NICA) is listed on Spotlight Stock Market. For further information, please visit www.nanologica.com.